Cellvax
Entity

  • Cellvax

    Created in 2001


  • Up & running (A)
    Existing signals show a regular activity

  • Social networks

    17 455

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    SMB

  • Location

    19 Av. du Professeur Cadiot, 94700 Maisons-Alfort, France

    Maisons-Alfort

    France

  • Employees

    Scale: 2-10

    Estimated: 7

  • SIREN

    438163511

  • Engaged catalyst

    0
    0 0

  • Added in Motherbase

    4 years, 2 months ago
Description
  • Value proposition

    Cellvax, founded in 2001, is a preclinical biotech company which provides in vitro and in vivo studies allowing accelera

    Cellvax, founded in 2001, is a preclinical CRO which provides innovating drug validation studies both in vitro and in vivo allowing to accelerate the drug development process for unmet needs related to severe human diseases, mainly in Cancer and Osteoarthritis (OA) fields. Cellvax is a fast-growing technology-driven preclinical service company. Today, Cellvax directly employs and through R&D collaborations motivated and differently skilled scientists and engineers, working in interdisciplinary teams on several innovative products.

    Preclinical studies CRO, Animal models, Cancer, Osteoarthritis, Bio-markers, Subcutaneous & Orthotopic cancer models, Syngeneic tumor models, PK/Bio-distribution, In vivo imaging, Histology, Toxicology studies, and Rodents & non-rodents

  • Original language

    Cellvax, founded in 2001, is a preclinical biotech company which provides in vitro and in vivo studies allowing accelera

    Cellvax, founded in 2001, is a preclinical CRO which provides innovating drug validation studies both in vitro and in vivo allowing to accelerate the drug development process for unmet needs related to severe human diseases, mainly in Cancer and Osteoarthritis (OA) fields. Cellvax is a fast-growing technology-driven preclinical service company. Today, Cellvax directly employs and through R&D collaborations motivated and differently skilled scientists and engineers, working in interdisciplinary teams on several innovative products.

  • Cellvax | Preclinical CRO | Expertise in Oncology and Osteoarthritis

    Cellvax is a preclinical CRO (Contract Research Organization) which provides in vitro and in vivo studies mainly in the fields of oncology (cancer) and osteoarthritis.

    • https://cellvax-pharma.com/
Catalyst interactions
Catalyst TypeTweets Articles
No interactions
Social network dynamics
Similar entities
BETA
Last news
Show all articles